{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

B2i Digital Named Marketing Partner for Centri Capital Conference 2026

March 27, 2026B2i Digital to Showcase Emerging Growth Companies Ahead of April 14, 2026 Conference at Nasdaq MarketSite in New York City NEW YORK, NY - March 27, 2026 (NEWMEDIAWIRE) - B2i Digital, Inc. has been named Marketing Partner for the 2026 Centri Capital Conference, taking place on Tuesday, April 14, 2026, at Nasdaq MarketSite in New York City.


Aptevo's Mipletamig Shows 86% Clinical Benefit Rate In Frontline AML As Emerging Data Demonstrate Additive Benefit To Standard Of Care Treatment

March 27, 2026By Meg Flippin, Benzinga DETROIT, MICHIGAN - March 27, 2026 (NEWMEDIAWIRE) - Acute myeloid leukemia (AML) is one of the most difficult blood cancers to treat – especially for older patients or those with other health conditions who cannot tolerate intensive chemotherapy. For many of these patients, treatment options are limited and outcomes remain poor.


Ethema Hires Veteran CFO James M. Poage

March 27, 2026WEST PALM BEACH, FL - March 27, 2026 (NEWMEDIAWIRE) - Ethema Health Corporation (OTCID: GRST) (“Ethema” “GRST” or the “Company”), and its Board of Directors, announces the appointment of James M. Poage as CFO.


CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events

March 27, 2026SAN DIEGO, CA - March 27, 2026 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), developer of CardioDialysisTM, a medical device that enables continuous broad-spectrum clearance of inflammatory and pathogenic molecules from the bloodstream, today released the following note authored by CEO and inventor, Jim Joyce.


Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention

March 27, 2026Integration Strengthens Onboarding and Transaction Workflows for Merchants Operating in Regulated, Specialized, and High-Compliance Sectors SAN CLEMENTE, CA - March 27, 2026 (NEWMEDIAWIRE) - Eco Science Solutions, Inc. (OTC: ESSI), a financial technology company focused on compliance-oriented payments infrastructure, today announced the integration of IDScan.


HKTDC's Response to Hong Kong's Export Figures for February

March 27, 2026HONG KONG - March 27, 2026 (NEWMEDIAWIRE) - The Census and Statistics Department today released the latest external merchandise trade statistics. In February 2026, the total value of merchandise exports increased by 24.


Catalyst Crew Technologies Introduces CardioAI, An AI-Driven Platform for Cardiovascular Risk Assessment and Clinical Decision Support

March 27, 2026CARACAS, VENEZUELA - March 26, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced the ongoing development of CardioAI, an artificial intelligence-enabled module designed to support cardiovascular risk assessment and predictive modeling.


Stefan Bauerreis Becomes New Chief Financial Officer (CFO) of Medios AG

March 26, 2026BERLIN - March 26, 2026 (NEWMEDIAWIRE) - The Supervisory Board of Medios AG has appointed Stefan Bauerreis as a member of the Executive Board and as the Company’s new Chief Financial Officer (CFO), effective April 15, 2026. He succeeds Falk Neukirch, who - as announced on March 6, 2026 – will step down at his own request at the end of his regular term of office on April 30, 2026.


PNE AG Closes the 2025 Financial Year With Successful Operational Performance and Focuses on Core Markets and Profitability

March 26, 2026 Best total operating revenue in the Company’s history EBITDA before special effects at EUR 87. 0 million Transformation and efficiency programme launched Normalised EBITDA of between EUR 110 million and EUR 140 million expected for 2026 CUXHAVEN, GERMANY - March 26, 2026 (NEWMEDIAWIRE) - PNE AG successfully completed the 2025 financial year from an operational perspective and, despite a challenging market environment, confirmed its profitability in its core business.


Martial Arts History Museum Celebrates and Preserves Asian Culture in Los Angeles

March 26, 2026LOS ANGELES, CA - March 26, 2026 (NEWMEDIAWIRE) - The Martial Arts History Museum stands as a cultural cornerstone in Los Angeles, offering a rare and meaningful exploration of Asian history, traditions, and artistic expression. More than a museum of physical discipline, it serves as a bridge between generations and cultures, bringing the depth and beauty of Asian heritage to one of the most diverse cities in the world.


Soligenix (SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behcet Disease

March 26, 2026LOS ANGELES, CA - March 26, 2026 (NEWMEDIAWIRE) - Soligenix (NASDAQ: SNGX) announced the European Commission has granted orphan drug designation to dusquetide (SGX945) for the treatment of Behcet Disease, following a positive recommendation from the European Medicines Agency and supportive Phase 2a data demonstrating biological efficacy and safety. The designation provides up to 10 years of market exclusivity in the European Union and adds to existing FDA orphan and fast track designations, as the company advances its innate defense regulator platform targeting unmet needs in rare autoimmune conditions.


D-Wave Quantum (QBTS) to Premiere "Quantum Matters" Podcast

March 26, 2026LOS ANGELES, CA - March 26, 2026 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, recently announced that it will launch a new podcast series, “Quantum Matters,” on April 7, 2026.


Peapack-Gladstone Financial Corporation Announces $50 Million Preferred Stock Commitment

March 26, 2026BEDMINSTER, NJ - March 26, 2026 (NEWMEDIAWIRE) - Peapack-Gladstone Financial Corporation (NASDAQ: PGC) (the “Company”), the holding company for Peapack Private Bank & Trust, has announced a $50 million preferred stock commitment from affiliates of Strategic Value Bank Partners, a long-term investor focused on the banking sector. The commitment includes an initial $30 million private placement of non-cumulative perpetual convertible preferred stock, with the ability to issue up to an additional $20 million of preferred stock through the end of 2027.


Lexaria's Robust Patent Portfolio Continues to Grow

March 26, 2026Lexaria Receives 5 New Patents Including 2 for Diabetes Treatment Utilizing GLP-1 Drugs KELOWNA, BRITISH COLUMBIA - March 26, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (Nasdaq: LEXX), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to provide this update on additional new intellectual property (“IP”) granted to the Company as a result of its ongoing research and development (“R&D”) programs.


NeuroOne® Successfully Completes Limited Market Release of OneRF® Trigeminal Nerve Ablation System

March 26, 202612 Patients Successfully Treated Across Three Leading Centers, With All Patients Reporting Freedom From Pain* Early Experience Highlights Improved Patient Comfort, Short Procedure Times and Precise Localization EDEN PRAIRIE, MINN. - March 26, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced the completion of the limited market release of its OneRF® Trigeminal Nerve Ablation System following FDA 510(k) clearance in August 2025.


33 High Schools, Colleges Awarded Grants for CPR Training and Community Resources to Make Campuses Safer

March 26, 2026DALLAS - March 26, 2026 (NEWMEDIAWIRE) - According to American Heart Association data, 9 out of every 10 people who experience cardiac arrest outside of a hospital die, in part because they do not receive immediate CPR more than half of the time. To help change this, the American Heart Association, a relentless force changing the future of health for everyone everywhere, has awarded 32 Nation of Lifesaver™ financial grants to American Heart Association Heart Clubs at high schools and colleges in 20 states, including the District of Columbia.